Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Albemarle Corporation (ALB) Stock Forecast & Price Prediction United States | NYSE | Basic Materials | Specialty Chemicals
$163.89
-4.11 (-2.45%)Did ALB Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Albemarle is one of their latest high-conviction picks.
Based on our analysis of 39 Wall Street analysts, ALB has a bullish consensus with a median price target of $197.00 (ranging from $83.28 to $230.00). The overall analyst rating is Buy (7.9/10). Currently trading at $163.89, the median forecast implies a 20.2% upside. This outlook is supported by 13 Buy, 12 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Laurence Alexander at Jefferies, projecting a 40.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ALB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 18, 2026 | Evercore ISI Group | Stephen Richardson | In-Line | Maintains | $180.00 |
| Feb 17, 2026 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $216.00 |
| Feb 17, 2026 | B of A Securities | Rock Hoffman | Buy | Upgrade | $190.00 |
| Feb 13, 2026 | Citigroup | Patrick Cunningham | Neutral | Maintains | $190.00 |
| Feb 12, 2026 | Mizuho | John Roberts | Neutral | Maintains | $185.00 |
| Jan 28, 2026 | Jefferies | Laurence Alexander | Buy | Maintains | $230.00 |
| Jan 28, 2026 | JP Morgan | Jeffrey Zekauskas | Neutral | Maintains | $195.00 |
| Jan 26, 2026 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $174.00 |
| Jan 21, 2026 | Citigroup | Patrick Cunningham | Neutral | Maintains | $180.00 |
| Jan 21, 2026 | Oppenheimer | Colin Rusch | Outperform | Maintains | $207.00 |
| Jan 21, 2026 | Truist Securities | Peter Osterland | Buy | Upgrade | $205.00 |
| Jan 13, 2026 | Deutsche Bank | Corinne Blanchard | Buy | Upgrade | $185.00 |
| Jan 12, 2026 | UBS | Joshua Spector | Buy | Maintains | $205.00 |
| Jan 12, 2026 | Mizuho | John Roberts | Neutral | Maintains | $156.00 |
| Jan 12, 2026 | Scotiabank | Ben Isaacson | Sector Outperform | Upgrade | $200.00 |
| Jan 7, 2026 | Baird | Ben Kallo | Outperform | Upgrade | $210.00 |
| Jan 6, 2026 | Jefferies | Laurence Alexander | Buy | Maintains | $167.00 |
| Dec 19, 2025 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $135.00 |
| Dec 18, 2025 | Mizuho | John Roberts | Neutral | Maintains | $132.00 |
| Dec 18, 2025 | Citigroup | Patrick Cunningham | Neutral | Maintains | $150.00 |
The following stocks are similar to Albemarle based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Albemarle Corporation has a market capitalization of $19.31B with a P/E ratio of 33.5x. The company generates $5.14B in trailing twelve-month revenue with a -9.9% profit margin.
Revenue growth is +15.9% quarter-over-quarter, while maintaining an operating margin of +2.3% and return on equity of -4.7%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops and manufactures specialty chemicals.
Albemarle operates through three main segments: Energy Storage, Specialties, and Ketjen, generating revenue by producing and selling lithium compounds for batteries, bromine-based products, and refining catalysts. The company's integrated supply chain allows for cost-effective production and distribution, catering to various industries including automotive and clean energy.
Albemarle is a global leader in specialty chemicals with significant assets in low-cost brine operations and hard-rock lithium mines. The company employs around 8,300 people and is strategically positioned to benefit from the growing demand for battery materials, even amidst market cyclicality and lithium price fluctuations.
Basic Materials
Specialty Chemicals
7,800
Mr. Jerry Kent Masters Jr.
United States
1994
Albemarle (ALB) concluded the recent trading session at $163.89, signifying a -2.45% move from its prior day's close.
Here is how Albemarle (ALB) and NWPX Infrastructure (NWPX) have performed compared to their sector so far this year.
Albemarle (ALB) closed at $163.93 in the latest trading session, marking a -2.63% move from the prior day.
Albemarle (ALB) is currently a focus for Zacks.com users, indicating increased investor interest. Future developments for the stock are being closely monitored.
Increased interest in Albemarle (ALB) signals potential volatility or opportunity, prompting investors to evaluate its future performance and market position.
Albemarle (ALB) and NWPX Infrastructure (NWPX) have been assessed for their performance relative to their sector in the current year.
The performance comparison of Albemarle and NWPX Infrastructure against their sector can indicate their relative strength, potential growth, and investment opportunities within their industries.
Albemarle (ALB) closed at $163.89, reflecting a decline of 2.45% from the previous day's closing price.
Albemarle's 2.45% decline signals potential volatility, impacting investor sentiment and possibly influencing future trading strategies and valuations.
ALB has risen approximately 121% in six months due to an earnings beat, lithium price recovery, project ramp-ups, and a positive earnings outlook.
ALB's 121% surge signals strong market confidence due to earnings beats and lithium price recovery, indicating potential for continued growth and investment returns.
ALB sells a controlling stake in Ketjen to KPS while retaining a minority stake, raising $670M to reduce debt and enhance financial flexibility.
The sale of a controlling stake in Ketjen for $670M improves ALB's financial health, reduces debt, and enhances operational flexibility, potentially increasing shareholder value.
Albemarle (ALB) closed at $163.93, down 2.63% from the previous trading day.
Albemarle's drop of 2.63% signals potential volatility, impacting investor sentiment and indicating possible shifts in market demand or company performance.
Based on our analysis of 39 Wall Street analysts, Albemarle Corporation (ALB) has a median price target of $197.00. The highest price target is $230.00 and the lowest is $83.28.
According to current analyst ratings, ALB has 13 Buy ratings, 12 Hold ratings, and 0 Sell ratings. The stock is currently trading at $163.89. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ALB stock could reach $197.00 in the next 12 months. This represents a 20.2% increase from the current price of $163.89. Please note that this is a projection by Wall Street analysts and not a guarantee.
Albemarle operates through three main segments: Energy Storage, Specialties, and Ketjen, generating revenue by producing and selling lithium compounds for batteries, bromine-based products, and refining catalysts. The company's integrated supply chain allows for cost-effective production and distribution, catering to various industries including automotive and clean energy.
The highest price target for ALB is $230.00 from Laurence Alexander at Jefferies, which represents a 40.3% increase from the current price of $163.89.
The lowest price target for ALB is $83.28 from at , which represents a -49.2% decrease from the current price of $163.89.
The overall analyst consensus for ALB is bullish. Out of 39 Wall Street analysts, 13 rate it as Buy, 12 as Hold, and 0 as Sell, with a median price target of $197.00.
Stock price projections, including those for Albemarle Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.